# Repligen to Acquire BioLife Solutions in $1.5 Billion Deal

> ma · REPORTED · 2026-07-22

Repligen announced a definitive agreement to acquire BioLife Solutions in a deal valued at approximately $1.5 billion, broadening its bioprocessing portfolio with BioLife's cell culture media, biopreservation, and cold-chain products used in cell and gene therapy manufacturing.

About Repligen: Repligen is a life-science tools company supplying bioprocessing technologies including filtration, chromatography, and process analytics to biopharmaceutical manufacturers globally.

- Company: Repligen
- Sector: medical devices
- Primary source: https://www.mmm-online.com/news/rx-rundown-samsung-biologics-dimension-gsk-and-more/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.